{
    "nctId": "NCT04920656",
    "briefTitle": "Universal Genetic Testing Versus Guidelines-Directed Testing for Germline Pathogenic Variants Among Non-Western Patients With Breast Cancer",
    "officialTitle": "Universal Genetic Testing Versus Guidelines-Directed Testing for Germline Pathogenic Variants Among Non-Western Patients With Breast Cancer",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 1000,
    "primaryOutcomeMeasure": "Prevalence of pathogenic or likely pathogenic germline variants among newly diagnosed breast cancer patients tested by universal multigene panel testing or guideline-based targeted testing",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Adult patient, age \u2265 18 years at time of cancer diagnosis\n* Pathology proven diagnosis of breast cancer (including DCIS); any stage. (prior history of cancer is allowed)\n* Willingness to participate\n* Signed consent form.\n\nExclusion Criteria:\n\n- Major psychiatric disorder (defined as: patients followed by a psychiatrist and on antipsychotic medications",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}